Can tezepelumab help improve my sense of smell and taste over time?
Tezepelumab is a biologic drug that blocks a protein called thymic stromal lymphopoietin (TSLP), which is involved in airway inflammation. For people with chronic rhinosinusitis with nasal polyps (CRSwNP), loss of smell and taste is a common and bothersome symptom. Clinical trials show that tezepelumab can improve these senses, with effects starting within days and lasting for at least a year.
What the research says
A phase 3 trial called WAYPOINT studied 408 adults with uncontrolled CRSwNP who received either tezepelumab or placebo every 4 weeks for 52 weeks 16. The trial measured smell using the University of Pennsylvania Smell Identification Test (UPSIT) and a daily symptom diary. By week 4, patients on tezepelumab had significantly better smell scores than those on placebo, and these improvements grew larger by week 52 16. For example, the UPSIT score improved by about 9.5 points more with tezepelumab than placebo at 52 weeks 16. Improvements in daily smell scores were seen as early as day 7 16. The SNOT-22 questionnaire, which includes a loss of smell/taste item, also showed significant benefits with tezepelumab at both 4 and 52 weeks 16. Another analysis from the NAVIGATOR study in patients with severe asthma and a history of CRSwNP found similar sustained improvements in SNOT-22 scores with tezepelumab 5. While other biologics like mepolizumab also help CRSwNP symptoms 34, tezepelumab's effect on smell appears early and consistent.
What to ask your doctor
- How does tezepelumab compare with other biologics (like dupilumab or mepolizumab) for improving smell and taste?
- What are the potential side effects of tezepelumab, and how is it administered?
- How long might it take to notice improvements in smell and taste after starting tezepelumab?
- Is tezepelumab an option for me given my current treatments and overall health?
- Will my insurance cover tezepelumab, and what is the expected cost?
This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.